Literature DB >> 6446915

Increased thymidylate synthetase in 5-fluorodeoxyuridine resistant cultured hepatoma cells.

D G Priest, B E Ledford, M T Doig.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6446915     DOI: 10.1016/0006-2952(80)90607-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  11 in total

Review 1.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer.

Authors:  P Ragnhammar; H Blomgren
Journal:  Med Oncol       Date:  1995-09       Impact factor: 3.064

3.  Increased mutational rates in Chinese hamster ovary cells serially selected for drug resistance.

Authors:  E Drobetsky; M Meuth
Journal:  Mol Cell Biol       Date:  1983-10       Impact factor: 4.272

4.  Cell cycle patterns of thymidylate synthetase and 5,10-methylenetetrahydrofolate polyglutamates in cultured mouse hepatoma cells.

Authors:  D G Priest; M T Doig; B E Ledford
Journal:  Experientia       Date:  1982-01-15

Review 5.  Chemotherapeutic drug resistance in the management of head and neck cancer.

Authors:  H Bier
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

6.  Sequential methotrexate/5-FU: FdUMP formation and TS inhibition in a transplantable rodent colon adenocarcinoma.

Authors:  M H Berne; B G Gustavsson; O Almersjö; P C Spears; R Frösing
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

7.  Thymidylate synthetase overproduction in 5-fluorodeoxyuridine-resistant mouse fibroblasts.

Authors:  C Rossana; L Gollakota Rao; L F Johnson
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

8.  Evaluation of plasma 5-fluorouracil nucleoside levels in patients with metastatic breast cancer: relationships with toxicities.

Authors:  M Barberi-Heyob; B Weber; J L Merlin; C Dittrich; E A de Bruijn; E Luporsi; F Guillemin
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  Molecular characterisation of two cell lines selected for resistance to the folate-based thymidylate synthase inhibitor, ZD1694.

Authors:  S J Freemantle; A L Jackman; L R Kelland; A H Calvert; J Lunec
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

10.  Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines.

Authors:  A L Jackman; L R Kelland; R Kimbell; M Brown; W Gibson; G W Aherne; A Hardcastle; F T Boyle
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.